1. The combination of vancomycin and fecal microbiota transplantation is superior to only fidaxomicin or vancomycin for the treatment of recurrent Clostridium difficile infection, according to a Danish study.
2. Researchers found the emergency department was the most common location for patients to receive a C. diff diagnosis.
3. An antibiotic created by a researcher at Flinders University in Australia may be a breakthrough in the fight against C. diff.
4. Nonelderly patients are at risk for gastrointestinal symptoms for up to two years after C. diff infection, a study shows.
5. A study found that prior laxative use is common among hospitalized adults undergoing C. diff testing.
6. Patients hospitalized with C. diff infection experience high rates of 30-day readmission, a study shows.
7. Children using antibiotics and/or proton pump inhibitors face a higher risk of developing C. diff infection, according to a study.
8. A CDC report shows C. diff events in the U.S. reduced by 13 percent between 2016 and 2017.
9. Reducing total antibiotic use resulted in decreased rates of hospital-onset C. diff infection, according to a study.
10. The number of antibiotics given and hospitalization before admission affect the likelihood of contracting C. diff infection among acute leukemia patients, a study shows
11. Recent antibiotic use was strongly linked to the onset of community-associated C. diff infections in young children, researchers found.
12. A study shows that some C. diff infection contamination can be attributed to patients who transfer hospitals.
More articles on healthcare quality:
Joint Commission offers hospitals real-time quality metrics: 4 things to know
32% of hospitals earn ‘A’ safety grade in Leapfrog’s spring update
11 findings on antibiotic resistance
